January 7, 2022
REGENXBIO Announces FDA Clearance of IND for Clinical Trial of RGX-202, a Novel Gene Therapy Candidate for Duchenne Muscular Dystrophy
ROCKVILLE, Md., Jan. 6, 2022 /PRNewswire/ -- Potential one-time gene therapy for the treatment of Duchenne includes a novel, optimized…
January 5, 2022
Zalgen Labs’ move to Frederick is another sign of the BioHealth Capital Region’s strengths
Maryland biotech company Zalgen Labs has moved to Frederick, illustrating the magnetism of the biotech hub for leaders like its own Dr. Luis…
January 3, 2022
Dr. James Crowe, Director of the Vanderbilt Vaccine Center Visits Bloomberg Markets: America, and CNBC’s Squawk Box
On this snowy start to 2022, I wanted to share with you two interviews with AHEAD100 Chief Scientist Dr. James…
January 3, 2022
BHI Recruiting a Senior Analyst, Immediate Opening.
BioHealth Innovation (BHI) is an innovation intermediary that facilitates the commercialization of emerging technologies in the BioHealth Capital Region (Maryland,…
January 3, 2022
Best Tech Innovation Companies Exhibiting at the CES 2022
Global health tech companies are queueing up for one of the world’s largest in-person events of the New Year- CES…
January 3, 2022
Novavax Announces Initial Omicron Cross-Reactivity Data from COVID-19 Vaccine Booster and Adolescent Studies
Two-dose primary regimen of NVX-CoV2373 demonstrated cross-reactive immune responses against Omicron (B.1.1.529) and other variants Third dose produced increased immune…
January 3, 2022
THE ECONOMIC IMPACT OF THE UNIVERSITY SYSTEM OF MARYLAND
The University System of Maryland (USM) retained the Jacob France Institute of the University of Baltimore to prepare this update…